Jennifer Lyn Herron is Director of ChemoCentryx, Inc.. Currently has a direct ownership of 0 shares of CCXI, which is worth approximately $0. The most recent transaction as insider was on Oct 20, 2022, when has been sold 17,237 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jennifer Lyn Herron Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2022
SELL
Sale (or disposition) back to the issuer
-
17,237 Reduced 100.0%
0 Common Stock
Jun 28 2022
BUY
Grant, award, or other acquisition
-
17,237 Added 50.0%
17,237 Common Stock

Also insider at

GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
JLH

Jennifer Lyn Herron

Director
San Carlos, CA

Track Institutional and Insider Activities on CCXI

Follow ChemoCentryx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCXI shares.

Notify only if

Insider Trading

Get notified when an Chemo Centryx, Inc. insider buys or sells CCXI shares.

Notify only if

News

Receive news related to ChemoCentryx, Inc.

Track Activities on CCXI